Ignyta Company Profile (NASDAQ:RXDX)

About Ignyta

Ignyta logoIgnyta, Inc. is an oncology biotechnology company. The Company focuses on an integrated therapeutic (Rx) and companion diagnostic (Dx) strategy for treating cancer patients. Its Rx is focused on discovering, in licensing or acquiring, then developing and commercializing molecularly targeted therapies that, sequentially or in combination, are foundational for eradicating residual disease. Its Dx focuses on pairing the product candidates with biomarker-based companion diagnostics that are designed to identify, at the molecular level, the patients likely to benefit from the therapies. Its entrectinib is an orally bioavailable, small molecule tyrosine kinase inhibitor directed to the tropomyosin receptor kinase (Trk) family tyrosine kinase receptors (TrkA, TrkB and TrkC), ROS1 and anaplastic lymphoma kinase (ALK) proteins for the treatment of solid tumors. Its entrectinib is in Phase II/III of clinical development. Its taladegib is a small molecule and hedgehog or smoothened antagonist.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: RXDX
  • CUSIP:
Key Metrics:
  • Previous Close: $5.94
  • 50 Day Moving Average: $5.917
  • 200 Day Moving Average: $6.223
  • 52-Week Range: $4.63 - $15.20
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.23
  • P/E Growth: 0.000
  • Market Cap: $257.19M
  • Outstanding Shares: 41,651,000
  • Beta: 1.23
Profitability:
  • Return on Equity: -82.11%
  • Return on Assets: -57.06%
Debt:
  • Debt-to-Equity Ratio: 0.21%
  • Current Ratio: 10.64%
  • Quick Ratio: 10.64%
Additional Links:
Companies Related to Ignyta:

Analyst Ratings

Consensus Ratings for Ignyta (NASDAQ:RXDX) (?)
Ratings Breakdown: 6 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $17.67 (180.87% upside)
Analysts' Ratings History for Ignyta (NASDAQ:RXDX)
Show:
DateFirmActionRatingPrice TargetDetails
8/10/2016Piper Jaffray Cos.Lower Price TargetOverweight$32.00 -> $20.00View Rating Details
7/12/2016Credit Suisse Group AGReiterated RatingBuyView Rating Details
6/23/2016JPMorgan Chase & Co.Initiated CoverageOverweight$15.00View Rating Details
6/17/2016Cantor FitzgeraldReiterated RatingBuy$18.00View Rating Details
6/6/2016Jefferies GroupReiterated RatingBuy$20.00View Rating Details
5/12/2016Leerink SwannReiterated RatingBuyView Rating Details
(Data available from 10/1/2014 forward)

Earnings

Earnings History for Ignyta (NASDAQ:RXDX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/9/2016Q2($0.65)($0.70)ViewN/AView Earnings Details
5/10/2016Q1($0.68)($0.79)ViewListenView Earnings Details
3/14/2016Q415($0.57)($1.32)ViewN/AView Earnings Details
11/9/2015Q315($0.60)($0.49)ViewN/AView Earnings Details
8/10/2015Q215($0.65)($0.51)ViewListenView Earnings Details
5/11/2015Q115($0.79)($1.15)ViewListenView Earnings Details
4/14/2015($0.79)($1.05)ViewN/AView Earnings Details
3/17/2015Q414($0.59)($2.18)ViewN/AView Earnings Details
11/7/2014Q314$0.01($0.55)$215.50 millionViewN/AView Earnings Details
8/12/2014($0.26)($0.28)ViewN/AView Earnings Details
5/12/2014($0.37)($0.28)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Ignyta (NASDAQ:RXDX)
Current Year EPS Consensus Estimate: $-2.74 EPS
Next Year EPS Consensus Estimate: $-2.82 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.63)($0.50)($0.57)
Q2 20162($0.67)($0.57)($0.62)
Q3 20162($0.67)($0.63)($0.65)
Q4 20162($0.73)($0.69)($0.71)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Ignyta (NASDAQ:RXDX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Ignyta (NASDAQ:RXDX)
Insider Ownership Percentage: 15.10%
Institutional Ownership Percentage: 62.39%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/15/2016James A BristolDirectorBuy5,000$5.65$28,250.00View SEC Filing  
5/4/2016Alexander W CasdinDirectorBuy232,000$6.25$1,450,000.00View SEC Filing  
3/17/2016Jacob ChackoCFOBuy10,000$5.64$56,400.00View SEC Filing  
3/17/2016James L FreddoDirectorBuy3,000$5.39$16,170.00View SEC Filing  
3/17/2016Jonathan E LimCEOBuy24,852$5.51$136,934.52View SEC Filing  
12/16/2015Jacob ChackoCFOBuy1,500$12.00$18,000.00View SEC Filing  
8/20/2015City Hill Venture Partners I,major shareholderBuy8,480$12.90$109,392.00View SEC Filing  
6/15/2015Robert WildVPBuy1,200$16.35$19,620.00View SEC Filing  
3/20/2015Jonathan E LimCEOBuy20,000$9.01$180,200.00View SEC Filing  
3/17/2015Alexander W CasdinDirectorBuy408,750$10.00$4,087,500.00View SEC Filing  
11/24/2014Jacob ChackoCFOBuy1,598$6.46$10,323.08View SEC Filing  
8/19/2014Jacob ChackoCFOBuy1,840$7.53$13,855.20View SEC Filing  
8/15/2014Jonathan E LimCEOBuy5,000$7.60$38,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Ignyta (NASDAQ:RXDX)
DateHeadline
News IconIgnyta to Present at the Ladenburg Thalmann 2016 Healthcare Conference - Yahoo Sports (NASDAQ:RXDX)
sports.yahoo.com - September 24 at 11:32 AM
finance.yahoo.com logoIgnyta to Present at the Ladenburg Thalmann 2016 Healthcare Conference (NASDAQ:RXDX)
finance.yahoo.com - September 23 at 6:38 PM
News IconWhat are Brokerage Firms Saying About Ignyta, Inc. (NASDAQ:RXDX)? - Frisco Fastball (NASDAQ:RXDX)
friscofastball.com - September 20 at 12:26 PM
businesswire.com logoEORTC and Ignyta Expand Collaborative Agreement for Precision ... - Business Wire (press release) (NASDAQ:RXDX)
www.businesswire.com - September 19 at 7:03 PM
News IconStock Perspective: Ignyta, Inc. (NASDAQ:RXDX) Earnings in View - Frisco Fastball (NASDAQ:RXDX)
friscofastball.com - September 19 at 7:03 PM
businesswire.com logoEORTC and Ignyta Expand Collaborative Agreement for Precision Medicine (NASDAQ:RXDX)
www.businesswire.com - September 19 at 11:42 AM
News IconAnalysts Take Aim At This Stock's Earnings Estimates: Ignyta, Inc. (NASDAQ:RXDX) - Frisco Fastball (NASDAQ:RXDX)
friscofastball.com - September 17 at 6:39 PM
businesswire.com logoIgnyta to Present at 2016 Silicon Valley Bank Healthcare Capital and Connections Summit - Business Wire (press release) (NASDAQ:RXDX)
www.businesswire.com - September 16 at 6:55 PM
News IconEarnings Take Center Stage; Analysts Weighing in on Ignyta, Inc. (NASDAQ:RXDX) - Frisco Fastball (NASDAQ:RXDX)
friscofastball.com - September 16 at 6:55 PM
News IconSell-side is Weighing in on Ignyta, Inc. (NASDAQ:RXDX) Earnings & Targets - Frisco Fastball (NASDAQ:RXDX)
friscofastball.com - September 16 at 6:55 PM
4-traders.com logoIgnyta : to Present at 2016 Silicon Valley Bank Healthcare Capital and Connections Summit (NASDAQ:RXDX)
www.4-traders.com - September 15 at 7:12 PM
finance.yahoo.com logoIgnyta to Present at 2016 Silicon Valley Bank Healthcare Capital and Connections Summit (NASDAQ:RXDX)
au.finance.yahoo.com - September 14 at 7:17 PM
News IconStock Gapping Up Pre-Market: Ignyta, Inc. (NASDAQ:RXDX) - Post News (NASDAQ:RXDX)
www.kentuckypostnews.com - September 1 at 7:04 PM
News IconShares Gapping Higher Pre-Bell: Ignyta, Inc. (NASDAQ:RXDX) - Post News (NASDAQ:RXDX)
www.kentuckypostnews.com - September 1 at 10:18 AM
seekingalpha.com logoIgnyta Is Proof That Biotech Bargains Still Exist - Seeking Alpha (NASDAQ:RXDX)
seekingalpha.com - September 1 at 10:18 AM
smarteranalyst.com logoCompany Update (NASDAQ:RXDX): Ignyta Inc Announces Approval of an Investigational Device Exemption (IDE) for ... - Smarter Analyst (NASDAQ:RXDX)
www.smarteranalyst.com - September 1 at 10:18 AM
finance.yahoo.com logo7:01 am Ignyta announces FDA approval of an investigational device exemption for its RNA-based companion diagnostic, next-generation sequencing assay (NASDAQ:RXDX)
finance.yahoo.com - September 1 at 10:18 AM
businesswire.com logoIgnyta Announces Approval of an Investigational Device Exemption (IDE) for the Companion Diagnostic Assay to the STARTRK-2 Trial (NASDAQ:RXDX)
www.businesswire.com - August 31 at 12:24 PM
streetinsider.com logoIgnyta (RXDX) Receivs FDA Approval of IDE for Trailblaze Pharos Assay (NASDAQ:RXDX)
www.streetinsider.com - August 31 at 12:24 PM
finance.yahoo.com logoIGNYTA, INC. Financials (NASDAQ:RXDX)
finance.yahoo.com - August 19 at 7:07 PM
News IconIgnyta Announces Second Quarter 2016 Company Highlights and Financial Results (NASDAQ:RXDX)
www.cbs58.com - August 9 at 7:32 PM
sg.finance.yahoo.com logoIgnyta reports 2Q loss (NASDAQ:RXDX)
sg.finance.yahoo.com - August 9 at 7:32 PM
ftsenews.co.uk logoNew Broker Ratings For Ignyta, Inc. (RXDX) - FTSE News (NASDAQ:RXDX)
www.ftsenews.co.uk - August 4 at 7:43 PM
tradecalls.org logoLamond Capital Partners Exits Position in Ignyta Inc (RXDX) - Trade Calls (NASDAQ:RXDX)
www.tradecalls.org - July 23 at 6:40 PM
News IconWhat's Ignyta Inc Downside After Today's Huge Decline? - Consumer Eagle (NASDAQ:RXDX)
www.consumereagle.com - July 21 at 7:34 PM
News IconHow Analysts Rated Ignyta Inc (NASDAQ:RXDX) Last Week? - Consumer Eagle (NASDAQ:RXDX)
www.consumereagle.com - July 21 at 10:05 AM
News IconShares Experiencing a Downtrend: Ignyta, Inc. (NASDAQ:RXDX) - TGP (NASDAQ:RXDX)
telanaganapress.com - July 16 at 6:40 PM
News IconArmistice Capital LLC Increased Ignyta INC (NASDAQ:RXDX) by $4.42 Million as Shares Declined - Consumer Eagle (NASDAQ:RXDX)
www.consumereagle.com - July 16 at 6:40 PM
News IconShares Moving Down on the Week: Ignyta, Inc. (NASDAQ:RXDX) - Engelwood Daily (NASDAQ:RXDX)
www.engelwooddaily.com - July 16 at 6:40 PM
fiscalstandard.com logoBroker Outlook For Ignyta, Inc. (RXDX) - Fiscal Standard (NASDAQ:RXDX)
www.fiscalstandard.com - July 15 at 12:27 PM
news.cmlviz.com logoIgnyta Inc Realized Volatility Hits Extreme Level - CML News (NASDAQ:RXDX)
news.cmlviz.com - July 14 at 7:29 PM
News IconIgnyta, Inc. (NASDAQ:RXDX) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:RXDX)
www.engelwooddaily.com - July 14 at 10:51 AM
News IconInsiders Increasing Positions in: Ignyta, Inc. (NASDAQ:RXDX) - Press Telegraph (NASDAQ:RXDX)
presstelegraph.com - July 14 at 10:51 AM
News IconHow Many Ignyta Inc (NASDAQ:RXDX)'s Analysts Are Bearish? - Consumer Eagle (NASDAQ:RXDX)
www.consumereagle.com - July 14 at 10:51 AM
News IconWall Street Ratings and Target Price Views on Ignyta, Inc. (NASDAQ:RXDX) - Telanagana Press (NASDAQ:RXDX)
telanaganapress.com - July 11 at 7:09 PM
fiscalstandard.com logoIgnyta, Inc. (RXDX) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:RXDX)
www.fiscalstandard.com - July 10 at 6:28 PM
News IconArmistice Capital LLC Increased Ignyta INC (NASDAQ:RXDX) by $4.42 Million as Shares Declined - Engelwood Daily (NASDAQ:RXDX)
www.engelwooddaily.com - July 9 at 10:19 AM
fiscalstandard.com logoIgnyta, Inc. (RXDX) Current Analyst Ratings - Fiscal Standard (NASDAQ:RXDX)
www.fiscalstandard.com - July 9 at 10:19 AM
finance.yahoo.com logoIgnyta to Present at 2016 Cantor Fitzgerald Healthcare Conference (NASDAQ:RXDX)
finance.yahoo.com - July 7 at 4:01 PM
News IconStock Tracking Down This Month; Investor Alert on Ignyta, Inc. (NASDAQ:RXDX) - Engelwood Daily (NASDAQ:RXDX)
www.engelwooddaily.com - July 7 at 10:00 AM
News IconCan Ignyta, Inc. (NASDAQ:RXDX) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:RXDX)
www.engelwooddaily.com - July 7 at 10:00 AM
finance.yahoo.com logoIgnyta Appoints Dr. Christian V. Kuhlen as General Counsel (NASDAQ:RXDX)
finance.yahoo.com - July 5 at 9:00 AM
News IconIgnyta Inc Stock Price Increases Today - Engelwood Daily (NASDAQ:RXDX)
www.engelwooddaily.com - July 4 at 6:23 PM
finance.yahoo.com logoIgnyta Secures $42 Million Term Loan Facility (NASDAQ:RXDX)
finance.yahoo.com - July 2 at 6:47 PM
News IconTracking Stock Volatility for: Ignyta, Inc. (NASDAQ:RXDX) - Engelwood Daily (NASDAQ:RXDX)
www.engelwooddaily.com - July 1 at 7:15 PM
biz.yahoo.com logoIGNYTA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligatio (NASDAQ:RXDX)
biz.yahoo.com - July 1 at 4:03 PM
tradecalls.org logoJP Morgan Initiates Coverage on Ignyta Inc to Overweight - Trade Calls (NASDAQ:RXDX)
www.tradecalls.org - June 30 at 7:31 PM
News IconWere Analysts Bearish Ignyta Inc (NASDAQ:RXDX) This Week? - Engelwood Daily (NASDAQ:RXDX)
www.engelwooddaily.com - June 29 at 7:06 PM
News IconCovering the Bases on Ignyta, Inc. (NASDAQ:RXDX): Where is the Stock Going? - Press Telegraph (NASDAQ:RXDX)
presstelegraph.com - June 28 at 12:01 PM
fiscalstandard.com logoNext Weeks Broker Price Targets For Ignyta, Inc. (RXDX) - Fiscal Standard (NASDAQ:RXDX)
www.fiscalstandard.com - June 27 at 7:09 PM

Social

Ignyta (NASDAQ:RXDX) Chart for Saturday, October, 1, 2016


Last Updated on 10/1/2016 by MarketBeat.com Staff